Sp1	B-protein
functions	O
in	O
a	O
chromatin	B-DNA
-dependent	O
manner	O
to	O
augment	O
human	B-DNA
alpha-globin	I-DNA
promoter	I-DNA
activity	O
.	O

The	O
5	B-DNA
'	I-DNA
flanking	I-DNA
region	I-DNA
of	O
the	O
human	B-DNA
alpha-globin	I-DNA
gene	I-DNA
is	O
highly	O
G	O
+	O
C	O
rich	O
and	O
contains	O
multiple	O
copies	O
of	O
the	O
consensus	B-DNA
sequence	I-DNA
for	O
the	O
Sp1	B-DNA
binding	I-DNA
site	I-DNA
.	O

We	O
investigated	O
the	O
role	O
of	O
this	O
G	B-DNA
+	I-DNA
C-rich	I-DNA
region	I-DNA
in	O
augmenting	O
alpha-globin	B-DNA
promoter	I-DNA
activity	O
in	O
the	O
presence	O
of	O
the	O
far-upstream	B-DNA
alpha-globin	I-DNA
enhancer	I-DNA
,	O
HS-40	B-DNA
.	O

We	O
show	O
that	O
in	O
transiently	B-cell_line
transfected	I-cell_line
erythroid	I-cell_line
cells	I-cell_line
,	O
deletion	O
of	O
the	O
alpha-globin	B-DNA
G	I-DNA
+	I-DNA
C-rich	I-DNA
5	I-DNA
'	I-DNA
flanking	I-DNA
region	I-DNA
has	O
no	O
effect	O
on	O
alpha-globin	B-DNA
promoter	I-DNA
activity	O
.	O

However	O
,	O
upon	O
stable	O
integration	O
into	O
chromatin	B-DNA
,	O
deletion	O
of	O
this	O
region	O
causes	O
a	O
nearly	O
90	O
%	O
decrease	O
in	O
promoter	O
activity	O
compared	O
with	O
expression	O
from	O
an	O
alpha-globin	B-DNA
promoter	I-DNA
retaining	O
this	O
region	O
.	O

These	O
results	O
suggest	O
that	O
the	O
alpha-globin	B-DNA
G	I-DNA
+	I-DNA
C-rich	I-DNA
5	I-DNA
'	I-DNA
flanking	I-DNA
region	I-DNA
augments	O
alpha-globin	B-DNA
promoter	I-DNA
activity	O
in	O
a	O
chromatin	B-DNA
-dependent	O
manner	O
.	O

We	O
further	O
show	O
that	O
this	O
G	B-DNA
+	I-DNA
C-rich	I-DNA
region	I-DNA
is	O
required	O
for	O
the	O
activation	O
of	O
alpha-globin	B-DNA
gene	I-DNA
expression	O
during	O
erythroid	O
differentiation	O
.	O

Finally	O
,	O
we	O
show	O
by	O
both	O
footprint	O
analysis	O
and	O
functional	O
assays	O
that	O
the	O
ability	O
of	O
the	O
G	B-DNA
+	I-DNA
C-rich	I-DNA
region	I-DNA
to	O
increase	O
alpha-globin	B-DNA
promoter	I-DNA
activity	O
from	O
a	O
stably	O
integrated	O
alpha-globin	B-DNA
gene	I-DNA
is	O
mediated	O
by	O
its	O
multiple	B-DNA
binding	I-DNA
sites	I-DNA
for	O
the	O
transcription	B-protein
factor	I-protein
Sp1	B-protein
.	O

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
Vol	NULL
.	NULL

92	NULL
,	NULL
pp	NULL
.	NULL

7237-7241	NULL
,	NULL
August	NULL
1995	NULL
Genetics	NULL
Spl	NULL
functions	NULL
in	NULL
a	NULL
chromatin-dependent	NULL
manner	NULL
to	NULL
augment	NULL
human	NULL
a-globin	NULL
promoter	NULL
activity	NULL
M.	NULL
D.	NULL
PonpELt	NULL
,	NULL
S.	NULL
MurpHy	NULL
?	NULL

t	NULL
,	NULL
L.	NULL
PEarsont	NULL
,	NULL
C	NULL
.	NULL

CrRapDpock	NULL
?	NULL

,	NULL
anp	NULL
N.	NULL
J.	NULL
Prouproott	NULL
*The	NULL
Sir	NULL
William	NULL
Dunn	NULL
School	NULL
of	NULL
Pathology	NULL
,	NULL
Chemical	NULL
Pathology	NULL
Unit	NULL
,	NULL
South	NULL
Parks	NULL
Road	NULL
,	NULL
Oxford	NULL
University	NULL
,	NULL
Oxford	NULL
,	NULL
OX1	NULL
3RE	NULL
,	NULL
United	NULL
Kingdom	NULL
;	NULL
and	NULL
*Medical	NULL
Research	NULL
Council	NULL
,	NULL
Molecular	NULL
Haematology	NULL
Unit	NULL
,	NULL
Institute	NULL
of	NULL
Molecular	NULL
Medicine	NULL
,	NULL
John	NULL
Radcliffe	NULL
Hospital	NULL
,	NULL
Headington	NULL
,	NULL
Oxford	NULL
,	NULL
OX3	NULL
IDU	NULL
,	NULL
United	NULL
Kingdom	NULL
Communicated	NULL
by	NULL
David	NULL
Weatherall	NULL
,	NULL
University	NULL
of	NULL
Oxford	NULL
,	NULL
Oxford	NULL
,	NULL
United	NULL
Kingdom	NULL
,	NULL
May	NULL
2	NULL
,	NULL
1995	NULL
(	NULL
received	NULL
for	NULL
review	NULL
February	NULL
10	NULL
,	NULL
1995	NULL
)	NULL
ABSTRACT	NULL
The	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
-globin	NULL
gene	NULL
is	NULL
highly	NULL
G+C	NULL
rich	NULL
and	NULL
contains	NULL
multiple	NULL
copies	NULL
of	NULL
the	NULL
consensus	NULL
sequence	NULL
for	NULL
the	NULL
Spl	NULL
binding	NULL
site	NULL
.	NULL

We	NULL
investigated	NULL
the	NULL
role	NULL
of	NULL
this	NULL
G+C-rich	NULL
region	NULL
in	NULL
augmenting	NULL
a-globin	NULL
promoter	NULL
activity	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
far-upstream	NULL
-globin	NULL
enhancer	NULL
,	NULL
HS-40	NULL
.	NULL

We	NULL
show	NULL
that	NULL
in	NULL
transiently	NULL
transfected	NULL
erythroid	NULL
cells	NULL
,	NULL
deletion	NULL
of	NULL
the	NULL
«	NULL
-globin	NULL
G+C-rich	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
a-globin	NULL
promoter	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
upon	NULL
stable	NULL
integration	NULL
into	NULL
chromatin	NULL
,	NULL
deletion	NULL
of	NULL
this	NULL
region	NULL
causes	NULL
a	NULL
nearly	NULL
90	NULL
%	NULL
decrease	NULL
in	NULL
promoter	NULL
activity	NULL
compared	NULL
with	NULL
expression	NULL
from	NULL
an	NULL
a-globin	NULL
promoter	NULL
retaining	NULL
this	NULL
region	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
-globin	NULL
G+C-rich	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
augments	NULL
a-globin	NULL
promoter	NULL
activity	NULL
in	NULL
a	NULL
chromatin-dependent	NULL
manner	NULL
.	NULL

We	NULL
further	NULL
show	NULL
that	NULL
this	NULL
G+C-rich	NULL
region	NULL
is	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
-globin	NULL
gene	NULL
expression	NULL
during	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
show	NULL
by	NULL
both	NULL
footprint	NULL
analysis	NULL
and	NULL
functional	NULL
assays	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
G+C-rich	NULL
region	NULL
to	NULL
increase	NULL
-globin	NULL
promoter	NULL
activity	NULL
from	NULL
a	NULL
stably	NULL
integrated	NULL
-globin	NULL
gene	NULL
is	NULL
mediated	NULL
by	NULL
its	NULL
multiple	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
Sp1	NULL
.	NULL

The	NULL
human	NULL
a-globin	NULL
gene	NULL
cluster	NULL
lies	NULL
within	NULL
an	NULL
early	NULL
replicating	NULL
G+C-rich	NULL
isochore	NULL
close	NULL
to	NULL
the	NULL
telomere	NULL
of	NULL
the	NULL
short	NULL
arm	NULL
of	NULL
chromosome	NULL
16	NULL
.	NULL

It	NULL
consists	NULL
of	NULL
three	NULL
functional	NULL
genes	NULL
arranged	NULL
5'-	NULL
{	NULL
2-a2-a1-3	NULL
'	NULL
.	NULL

As	NULL
with	NULL
the	NULL
-globin	NULL
genes	NULL
,	NULL
the	NULL
«	NULL
-like	NULL
globin	NULL
genes	NULL
are	NULL
erythroid	NULL
specific	NULL
.	NULL

However	NULL
,	NULL
they	NULL
are	NULL
structurally	NULL
quite	NULL
different	NULL
to	NULL
the	NULL
-globin	NULL
genes	NULL
in	NULL
that	NULL
they	NULL
are	NULL
highly	NULL
G+C	NULL
rich	NULL
,	NULL
associated	NULL
with	NULL
CpG	NULL
islands	NULL
,	NULL
and	NULL
lack	NULL
scaffold-associated	NULL
regions	NULL
(	NULL
for	NULL
review	NULL
,	NULL
see	NULL
ref	NULL
.	NULL

1	NULL
)	NULL
.	NULL

High-level	NULL
expression	NULL
of	NULL
genes	NULL
within	NULL
the	NULL
-globin	NULL
gene	NULL
cluster	NULL
is	NULL
dependent	NULL
upon	NULL
sequences	NULL
located	NULL
far	NULL
upstream	NULL
from	NULL
the	NULL
«	NULL
-globin	NULL
gene	NULL
cluster	NULL
.	NULL

An	NULL
erythroid-specific	NULL
DNase	NULL
1-hypersensitive	NULL
site	NULL
located	NULL
40	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
{	NULL
-globin	NULL
gene	NULL
(	NULL
HS-40	NULL
)	NULL
confers	NULL
high	NULL
levels	NULL
of	NULL
erythroid-specific	NULL
expression	NULL
to	NULL
a	NULL
linked	NULL
a-	NULL
or	NULL
{	NULL
-globin	NULL
gene	NULL
in	NULL
stably	NULL
integrated	NULL
erythroid	NULL
cells	NULL
or	NULL
transgenic	NULL
mice	NULL
(	NULL
2-5	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
HS-40	NULL
lies	NULL
within	NULL
an	NULL
intron	NULL
of	NULL
a	NULL
widely	NULL
expressed	NULL
gene	NULL
of	NULL
unknown	NULL
function	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
«	NULL
-globin	NULL
gene	NULL
contains	NULL
multiple	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
transcription	NULL
factor	NULL
Sp1	NULL
and	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
CpG	NULL
island	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

CpG	NULL
islands	NULL
in	NULL
general	NULL
have	NULL
a	NULL
chromatin	NULL
structure	NULL
different	NULL
from	NULL
that	NULL
of	NULL
bulk	NULL
chromatin	NULL
in	NULL
that	NULL
they	NULL
are	NULL
deficient	NULL
in	NULL
histone	NULL
H1	NULL
,	NULL
contain	NULL
hyperacetylated	NULL
histones	NULL
H3	NULL
and	NULL
H4	NULL
,	NULL
and	NULL
include	NULL
nucleosome-free	NULL
segments	NULL
of	NULL
DNA	NULL
(	NULL
8	NULL
)	NULL
.	NULL

It	NULL
therefore	NULL
seems	NULL
plausible	NULL
that	NULL
this	NULL
G+C-rich	NULL
5°	NULL
flanking	NULL
region	NULL
may	NULL
be	NULL
important	NULL
for	NULL
high-level	NULL
expression	NULL
from	NULL
an	NULL
«	NULL
-globin	NULL
gene	NULL
stably	NULL
integrated	NULL
into	NULL
chromatin	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
examined	NULL
the	NULL
role	NULL
played	NULL
by	NULL
this	NULL
highly	NULL
G+C-rich	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
in	NULL
«	NULL
-globin	NULL
gene	NULL
expression	NULL
upon	NULL
erythroid	NULL
differentiation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
characterized	NULL
specific	NULL
nuclear	NULL
regulatory	NULL
proteins	NULL
in	NULL
erythroid	NULL
cells	NULL
that	NULL
interact	NULL
with	NULL
this	NULL
region	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

§1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

7237	NULL
MATERIALS	NULL
AND	NULL
METHODS	NULL
DNA	NULL
Constructs	NULL
.	NULL

All	NULL
DNA	NULL
constructs	NULL
employed	NULL
in	NULL
this	NULL
study	NULL
are	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
.	NULL

The	NULL
constructs	NULL
-750/CAT	NULL
,	NULL
-267/CAT	NULL
,	NULL
-85/CAT	NULL
,	NULL
and	NULL
-55/CAT	NULL
contain	NULL
750	NULL
,	NULL
267	NULL
,	NULL
85	NULL
,	NULL
and	NULL
55	NULL
bp	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
«	NULL
-globin	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
(	NULL
cap	NULL
=	NULL
0	NULL
)	NULL
in	NULL
the	NULL
Bg	NULL
II	NULL
site	NULL
of	NULL
the	NULL
plasmid	NULL
pSVOCAT	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
plasmid	NULL
~750*/CAT	NULL
(	NULL
CCAAT	NULL
box	NULL
mutant	NULL
)	NULL
was	NULL
produced	NULL
by	NULL
digesting	NULL
the	NULL
plasmid	NULL
-750/CAT	NULL
with	NULL
Nae	NULL
I	NULL
and	NULL
Eag	NULL
I	NULL
.	NULL

The	NULL
plasmid	NULL
was	NULL
purified	NULL
and	NULL
ligated	NULL
with	NULL
a	NULL
Nae	NULL
I-Hinfl	NULL
and	NULL
a	NULL
Hinfl-Eag	NULL
I	NULL
a-globin	NULL
promoter	NULL
fragment	NULL
containing	NULL
a	NULL
mutated	NULL
CCAAT	NULL
box	NULL
(	NULL
CCAAT	NULL
to	NULL
CGAGT	NULL
)	NULL
.	NULL

The	NULL
plasmids	NULL
Sp1/-85/CAT	NULL
and	NULL
Sp1*/-85/CAT	NULL
were	NULL
produced	NULL
by	NULL
digesting	NULL
the	NULL
plasmid	NULL
-750/CAT	NULL
with	NULL
Nde	NULL
I	NULL
and	NULL
Sma	NULL
1	NULL
.	NULL

The	NULL
ends	NULL
were	NULL
filled	NULL
in	NULL
with	NULL
the	NULL
Klenow	NULL
fragment	NULL
of	NULL
DNA	NULL
polymerase	NULL
I	NULL
and	NULL
ligated	NULL
with	NULL
a	NULL
19-mer	NULL
oligonucleotide	NULL
containing	NULL
either	NULL
an	NULL
Spl	NULL
(	NULL
based	NULL
on	NULL
simian	NULL
virus	NULL
40	NULL
ori	NULL
se-quences	NULL
)	NULL
or	NULL
mutant	NULL
Spl	NULL
binding	NULL
site	NULL
(	NULL
GGAACTGGGCGG-AGTTAGG	NULL
or	NULL
GGAACTGGGATGAGTTAGG	NULL
)	NULL
.	NULL

A	NULL
total	NULL
of	NULL
six	NULL
wild-type	NULL
or	NULL
mutant	NULL
Spl	NULL
binding	NULL
sites	NULL
were	NULL
put	NULL
into	NULL
each	NULL
plasmid	NULL
.	NULL

To	NULL
produce	NULL
a-globin	NULL
promoter/CAT	NULL
constructs	NULL
containing	NULL
HS-40	NULL
and/or	NULL
Neo	NULL
,	NULL
a	NULL
4.0-kb	NULL
BamHI	NULL
fragment	NULL
containing	NULL
HS-40	NULL
and/or	NULL
an	NULL
EcoR	NULL
I-BamHI	NULL
fragment	NULL
containing	NULL
a	NULL
simian	NULL
virus	NULL
40	NULL
promoter	NULL
linked	NULL
to	NULL
a	NULL
Neo	NULL
gene	NULL
were	NULL
ligated	NULL
to	NULL
a	NULL
BamHI	NULL
recognition	NULL
site	NULL
and/or	NULL
a	NULL
blunt-ended	NULL
Pvu	NULL
I	NULL
recognition	NULL
site	NULL
of	NULL
each	NULL
construct	NULL
.	NULL

Tissue	NULL
Culture	NULL
,	NULL
Cell	NULL
Transfection	NULL
,	NULL
and	NULL
CAT	NULL
Assays	NULL
.	NULL

Putko	NULL
,	NULL
murine	NULL
erythroleukemia	NULL
(	NULL
MEL	NULL
)	NULL
585	NULL
,	NULL
and	NULL
MEL	NULL
707	NULL
cells	NULL
were	NULL
maintained	NULL
as	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

K562	NULL
cells	NULL
were	NULL
maintained	NULL
as	NULL
above	NULL
,	NULL
except	NULL
that	NULL
10	NULL
%	NULL
(	NULL
vol/vol	NULL
)	NULL
fetal	NULL
calf	NULL
serum	NULL
was	NULL
employed	NULL
.	NULL

Putko	NULL
and	NULL
MEL	NULL
cells	NULL
were	NULL
electroporated	NULL
with	NULL
0.75-50	NULL
ug	NULL
of	NULL
DNA	NULL
as	NULL
described	NULL
(	NULL
10	NULL
)	NULL
.	NULL

K562	NULL
cells	NULL
were	NULL
transfected	NULL
as	NULL
above	NULL
,	NULL
employing	NULL
a	NULL
current	NULL
of	NULL
1.2	NULL
kV	NULL
and	NULL
25	NULL
uF	NULL
.	NULL

To	NULL
generate	NULL
stable	NULL
lines	NULL
,	NULL
cells	NULL
were	NULL
transfected	NULL
as	NULL
above	NULL
.	NULL

Forty-eight	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
placed	NULL
in	NULL
selection	NULL
medium	NULL
containing	NULL
1.0	NULL
mg	NULL
of	NULL
G418	NULL
per	NULL
ml	NULL
.	NULL

Individual	NULL
clones	NULL
or	NULL
pools	NULL
of	NULL
G418-resistant	NULL
clones	NULL
were	NULL
then	NULL
employed	NULL
for	NULL
CAT	NULL
analysis	NULL
To	NULL
induce	NULL
terminal	NULL
erythroid	NULL
differentiation	NULL
,	NULL
MEL	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
5	NULL
mM	NULL
hexamethylenebisacetamide	NULL
(	NULL
HMBA	NULL
)	NULL
and	NULL
25	NULL
uM	NULL
hemin	NULL
for	NULL
a	NULL
period	NULL
of	NULL
60-72	NULL
h.	NULL
All	NULL
CAT	NULL
assays	NULL
and	NULL
cotransfection	NULL
controls	NULL
were	NULL
performed	NULL
according	NULL
to	NULL
Pondel	NULL
et	NULL
al	NULL
.	NULL

(	NULL
10	NULL
)	NULL
.	NULL

Copy	NULL
Number	NULL
Analysis	NULL
.	NULL

To	NULL
determine	NULL
a-globin	NULL
promoter/	NULL
CAT/HS-40	NULL
copy	NULL
number	NULL
in	NULL
cell	NULL
clones	NULL
,	NULL
DNA	NULL
was	NULL
isolated	NULL
according	NULL
to	NULL
Maniatis	NULL
et	NULL
al	NULL
.	NULL

(	NULL
11	NULL
)	NULL
and	NULL
subjected	NULL
to	NULL
Southern	NULL
blot	NULL
analysis	NULL
by	NULL
employing	NULL
a	NULL
4.0-kb	NULL
BamHI	NULL
HS-40	NULL
DNA	NULL
fragment	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Copy	NULL
number	NULL
was	NULL
quantitated	NULL
as	NULL
described	NULL
(	NULL
4	NULL
)	NULL
.	NULL

DNase	NULL
Protection	NULL
Studies	NULL
.	NULL

Probes	NULL
for	NULL
these	NULL
studies	NULL
were	NULL
prepared	NULL
by	NULL
digesting	NULL
a	NULL
plasmid	NULL
containing	NULL
the	NULL
-globin	NULL
promoter	NULL
with	NULL
either	NULL
Nae	NULL
I	NULL
or	NULL
Eag	NULL
I	NULL
,	NULL
followed	NULL
by	NULL
incorporation	NULL
of	NULL
an	NULL
a-P-labeled	NULL
nucleotide	NULL
with	NULL
the	NULL
Klenow	NULL
enzyme	NULL
.	NULL

A	NULL
total	NULL
of	NULL
10	NULL
fmol	NULL
of	NULL
purified	NULL
probe	NULL
was	NULL
used	NULL
in	NULL
a	NULL
reaction	NULL
as	NULL
described	NULL
by	NULL
Murphy	NULL
et	NULL
al	NULL
.	NULL

(	NULL
12	NULL
)	NULL
,	NULL
with	NULL
the	NULL
following	NULL
exceptions	NULL
:	NULL
reactions	NULL
contained	NULL
6.25	NULL
mM	NULL
MgC	NULL
]	NULL
;	NULL
;	NULL
no	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
-poly	NULL
(	NULL
dI-	NULL
Abbreviations	NULL
:	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
MEL	NULL
,	NULL
murine	NULL
erythroleukemia	NULL
;	NULL
HMBA	NULL
,	NULL
hexamethylenebisacetamide	NULL
.	NULL

7238	NULL
Genetics	NULL
:	NULL
Pondel	NULL
et	NULL
al	NULL
.	NULL

A	NULL
-40	NULL
0	NULL
-20	NULL
-__	NULL
HS40	NULL
ge	NULL
a2	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
Sma	NULL
Hinf1	NULL
CCAAT	NULL
-	NULL
ATA	NULL
‘	NULL
Pst	NULL
]	NULL
cap	NULL
=0	NULL
C	NULL
HS40	NULL
.	NULL

NEQ	NULL
-750	NULL
+0	NULL
+	NULL
r	NULL
ii	NULL
CAT	NULL
l	NULL
~~	NULL
*	NULL
~750/CAT	NULL
Sma	NULL
*	NULL
=	NULL
C3AT	NULL
T	NULL
T	NULL
-750	NULL
r	NULL
CGAGT	NULL
CAT	NULL
+0	NULL
+	NULL
-750*/CAT	NULL
Sma	NULL
¥	NULL
)	NULL
+0000	NULL
-267/CAT	NULL
Nae	NULL
!	NULL

“	NULL
85	NULL
+	NULL
+	NULL
=	NULL
+	NULL
=	NULL
Sma	NULL
cat	NULL
+	NULL
-	NULL
85/CAT	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

(	NULL
4	NULL
)	NULL
The	NULL
three	NULL
func	NULL
--	NULL
=-	NULL
tional	NULL
human	NULL
a-globin	NULL
genes	NULL
and	NULL
a	NULL
.	NULL

HS-40	NULL
located	NULL
40	NULL
kb	NULL
upstream	NULL
of	NULL
~55	NULL
80	NULL
%	NULL
L	NULL
the	NULL
{	NULL
-globin	NULL
gene	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Line	NULL
dia-Eag1	NULL
cat	NULL
+0	NULL
-	NULL
S5/CAT	NULL
gram	NULL
of	NULL
the	NULL
human	NULL
a-globin	NULL
gene	NULL
.	NULL

9	NULL
6	NULL
=	NULL
Stippled	NULL
boxes	NULL
represent	NULL
exons	NULL
,	NULL
black	NULL
boxes	NULL
represent	NULL
consensus	NULL
-85	NULL
Sp1-binding	NULL
sequences	NULL
.	NULL

(	NULL
C	NULL
)	NULL
a-Glo-Sp1	NULL
+	NULL
+	NULL
_	NULL
§p1/-85/CAT	NULL
-	NULL
bin	NULL
promoter/chloramphenicol	NULL
Smal	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
constructs	NULL
indicating	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
-85	NULL
of	NULL
HS-40	NULL
and	NULL
Neo	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
Sp1*	NULL
+	NULL
0+	NULL
Smal	NULL
dC	NULL
)	NULL
was	NULL
added	NULL
for	NULL
the	NULL
studies	NULL
with	NULL
recombinant	NULL
Sp1	NULL
(	NULL
obtained	NULL
from	NULL
Promega	NULL
)	NULL
;	NULL
and	NULL
reactions	NULL
with	NULL
MEL	NULL
extract	NULL
contained	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
-poly	NULL
(	NULL
dI-dC	NULL
)	NULL
per	NULL
reaction	NULL
.	NULL

DNase	NULL
I	NULL
was	NULL
added	NULL
to	NULL
a	NULL
final	NULL
concentration	NULL
of	NULL
between	NULL
0.1	NULL
and	NULL
1.0	NULL
ug/ml	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
MEL	NULL
cells	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
one	NULL
strand	NULL
of	NULL
the	NULL
double-stranded	NULL
Sp1	NULL
and	NULL
mutant	NULL
Sp1	NULL
oligonucleotides	NULL
used	NULL
as	NULL
competitors	NULL
in	NULL
the	NULL
DNase	NULL
protection	NULL
analysis	NULL
are	NULL
listed	NULL
above	NULL
in	NULL
the	NULL
section	NULL
on	NULL
DNA	NULL
constructs	NULL
.	NULL

RESULTS	NULL
Comparison	NULL
of	NULL
a-Globin	NULL
Promoter	NULL
Activity	NULL
in	NULL
Transient	NULL
Versus	NULL
Stable	NULL
Erythroid	NULL
Cell	NULL
Transfections	NULL
.	NULL

To	NULL
characterize	NULL
specific	NULL
elements	NULL
in	NULL
the	NULL
a-globin	NULL
promoter	NULL
that	NULL
are	NULL
required	NULL
for	NULL
its	NULL
high-level	NULL
activity	NULL
,	NULL
a	NULL
series	NULL
of	NULL
hybrid	NULL
a-globin/CAT	NULL
constructs	NULL
were	NULL
produced	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

We	NULL
began	NULL
our	NULL
analysis	NULL
by	NULL
transiently	NULL
transfecting	NULL
three	NULL
constructs	NULL
(	NULL
-750/CAT/HS-40	NULL
,	NULL
-85/CAT/HS-40	NULL
,	NULL
and	NULL
-55/CAT/HS-40	NULL
)	NULL
into	NULL
MEL	NULL
cells	NULL
.	NULL

These	NULL
cells	NULL
can	NULL
be	NULL
induced	NULL
with	NULL
the	NULL
drug	NULL
HMBA	NULL
to	NULL
undergo	NULL
terminal	NULL
differentiation	NULL
into	NULL
erythroid	NULL
cells	NULL
and	NULL
subsequently	NULL
show	NULL
a	NULL
10-	NULL
to	NULL
20-fold	NULL
increase	NULL
in	NULL
endogenous	NULL
-globin	NULL
expression	NULL
(	NULL
14-16	NULL
)	NULL
.	NULL

We	NULL
previously	NULL
showed	NULL
that	NULL
HS-40	NULL
can	NULL
activate	NULL
a-globin	NULL
promoter	NULL
activity	NULL
in	NULL
transiently	NULL
transfected	NULL
erythroid	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
HMBA	NULL
,	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
above	NULL
constructs	NULL
displayed	NULL
similarly	NULL
low	NULL
levels	NULL
of	NULL
CAT	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Following	NULL
60	NULL
h	NULL
of	NULL
exposure	NULL
to	NULL
HMBA	NULL
,	NULL
CAT	NULL
expression	NULL
from	NULL
MEL	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
-750/	NULL
CAT	NULL
/HS-40	NULL
or	NULL
-85/CAT/HS-40	NULL
increased	NULL
on	NULL
average	NULL
8-fold	NULL
.	NULL

CAT	NULL
expression	NULL
from	NULL
-55/CAT/HS-40	NULL
,	NULL
however	NULL
,	NULL
increased	NULL
only	NULL
3-	NULL
to	NULL
4-fold	NULL
.	NULL

When	NULL
these	NULL
constructs	NULL
were	NULL
transiently	NULL
Sp1*/-85/CAT	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
relative	NULL
to	NULL
the	NULL
cap	NULL
site	NULL
is	NULL
indicated	NULL
.	NULL

transfected	NULL
into	NULL
the	NULL
human	NULL
erythroid-like	NULL
Putko	NULL
cell	NULL
line	NULL
,	NULL
expression	NULL
from	NULL
both	NULL
-750/CAT/HS-40	NULL
and	NULL
-85/CAT/	NULL
HS-40	NULL
was	NULL
similar	NULL
,	NULL
whereas	NULL
expression	NULL
from	NULL
the	NULL
-55/CAT/	NULL
HS-40	NULL
construct	NULL
was	NULL
75	NULL
%	NULL
lower	NULL
than	NULL
expression	NULL
from	NULL
the	NULL
above	NULL
constructs	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
HS-40	NULL
,	NULL
expression	NULL
from	NULL
all	NULL
constructs	NULL
was	NULL
close	NULL
to	NULL
background	NULL
levels	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

All	NULL
the	NULL
above	NULL
results	NULL
suggest	NULL
that	NULL
in	NULL
transiently	NULL
transfected	NULL
cells	NULL
,	NULL
the	NULL
a-globin	NULL
CCAAT	NULL
and	NULL
TATA	NULL
boxes	NULL
,	NULL
in	NULL
conjunction	NULL
with	NULL
HS-40	NULL
,	NULL
mediate	NULL
high	NULL
levels	NULL
of	NULL
«	NULL
-globin	NULL
expression	NULL
upon	NULL
erythroid	NULL
differentiation	NULL
.	NULL

When	NULL
the	NULL
above	NULL
and	NULL
additional	NULL
constructs	NULL
were	NULL
stably	NULL
integrated	NULL
into	NULL
MEL	NULL
cells	NULL
,	NULL
CAT	NULL
expression	NULL
prior	NULL
to	NULL
induction	NULL
with	NULL
HMBA	NULL
was	NULL
similarly	NULL
low	NULL
for	NULL
all	NULL
constructs	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Following	NULL
a	NULL
72-h	NULL
exposure	NULL
to	NULL
HMBA	NULL
,	NULL
CAT	NULL
expression	NULL
from	NULL
-750/CAT/HS-40/Neo	NULL
in	NULL
pools	NULL
of	NULL
stable	NULL
integrants	NULL
increased	NULL
on	NULL
average	NULL
16-fold	NULL
.	NULL

However	NULL
,	NULL
expression	NULL
from	NULL
-85/	NULL
CAT/HS-40/Neo	NULL
increased	NULL
slightly	NULL
less	NULL
than	NULL
2-fold	NULL
.	NULL

CAT	NULL
expression	NULL
from	NULL
-55/CAT/HS-40/Neo	NULL
was	NULL
no	NULL
longer	NULL
inducible	NULL
with	NULL
HMBA	NULL
.	NULL

When	NULL
these	NULL
constructs	NULL
were	NULL
stably	NULL
integrated	NULL
into	NULL
the	NULL
human	NULL
erythroid-like	NULL
line	NULL
K562	NULL
,	NULL
CAT	NULL
expression	NULL
from	NULL
-750/	NULL
CAT	NULL
/HS-40/Neo	NULL
was	NULL
,	NULL
on	NULL
average	NULL
,	NULL
9-fold	NULL
higher	NULL
than	NULL
expression	NULL
from	NULL
the	NULL
-85/CAT/HS-40/Neo	NULL
construct	NULL
.	NULL

Expression	NULL
from	NULL
the	NULL
-85/CAT/HS-40/Neo	NULL
was	NULL
3-fold	NULL
higher	NULL
than	NULL
expression	NULL
from	NULL
the	NULL
-55/CAT/HS-40/Neo	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

Primer	NULL
extension	NULL
analysis	NULL
on	NULL
RNA	NULL
from	NULL
the	NULL
above	NULL
stable	NULL
cell	NULL
pools	NULL
showed	NULL
that	NULL
transcription	NULL
from	NULL
these	NULL
constructs	NULL
initiated	NULL
at	NULL
the	NULL
correct	NULL
start	NULL
site	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
HS-40	NULL
,	NULL
no	NULL
significant	NULL
level	NULL
of	NULL
CAT	NULL
expression	NULL
from	NULL
any	NULL
of	NULL
these	NULL
constructs	NULL
was	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

CAT	NULL
expression	NULL
from	NULL
the	NULL
construct	NULL
-267/CAT/HS-40/	NULL
Neo	NULL
in	NULL
stably	NULL
integrated	NULL
MEL	NULL
cells	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
Genetics	NULL
:	NULL
Pondel	NULL
et	NULL
al	NULL
.	NULL

A	NULL
B	NULL
6o	NULL
40	NULL
50	NULL
30	NULL
40	NULL
30	NULL
20	NULL
20	NULL
10	NULL
10	NULL
&	NULL
$	NULL
°	NULL
g	NULL
0	NULL
``	NULL
&	NULL
k	NULL
&	NULL
8	NULL
B	NULL
2	NULL
g	NULL
$	NULL
*	NULL
Eo	NULL
&	NULL
Io	NULL
d	NULL
8	NULL
I	NULL
I	NULL
I	NULL
“	NULL
I	NULL
'—	NULL
3	NULL
C	NULL
D	NULL
yo	NULL
8	NULL
50	NULL
s-	NULL
40-so-	NULL
-	NULL
I	NULL
10-o-	NULL
il	NULL
=	NULL
q	NULL
--	NULL
-p	NULL
I	NULL
0	NULL
Y	NULL
-	NULL
g	NULL
2	NULL
C	NULL
8	NULL
%	NULL
8	NULL
w	NULL
w	NULL
w	NULL
<	NULL
T	NULL
1	NULL
I	NULL
R.	NULL
mid	NULL
N.	NULL
8	NULL
[	NULL
«	NULL
]	NULL
&	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

(	NULL
4	NULL
)	NULL
CAT	NULL
assay	NULL
from	NULL
HMBA-induced	NULL
(	NULL
black	NULL
bar	NULL
)	NULL
or	NULL
uninduced	NULL
(	NULL
white	NULL
bar	NULL
)	NULL
MEL	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
-750/CAT/	NULL
HS-40	NULL
,	NULL
-85/CAT/HS-40	NULL
,	NULL
and	NULL
-55/CAT/HS-40	NULL
.	NULL

Following	NULL
each	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
divided	NULL
into	NULL
two	NULL
flasks	NULL
,	NULL
one	NULL
of	NULL
which	NULL
received	NULL
HMBA	NULL
.	NULL

Data	NULL
represent	NULL
an	NULL
average	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
B	NULL
)	NULL
CAT	NULL
assays	NULL
from	NULL
pre-	NULL
(	NULL
white	NULL
bar	NULL
)	NULL
or	NULL
post-	NULL
(	NULL
black	NULL
bar	NULL
)	NULL
HMBA-induced	NULL
MEL	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
-750/CAT/HS-40	NULL
,	NULL
-750*/	NULL
CAT/HS-40	NULL
,	NULL
-267/CAT/HS-40	NULL
,	NULL
-85/CAT/HS-40	NULL
,	NULL
or	NULL
-55/CAT/	NULL
HS-40/Neo	NULL
constructs	NULL
.	NULL

Data	NULL
represent	NULL
an	NULL
average	NULL
from	NULL
four	NULL
independent	NULL
pools	NULL
of	NULL
stable	NULL
clones	NULL
(	NULL
>	NULL
100	NULL
clones	NULL
per	NULL
pool	NULL
)	NULL
per	NULL
construct	NULL
.	NULL

(	NULL
C	NULL
)	NULL
CAT	NULL
assay	NULL
from	NULL
Putko	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
0.75	NULL
,	NULL
1.5	NULL
,	NULL
or	NULL
3.75	NULL
ug	NULL
of	NULL
pSVOCAT	NULL
(	NULL
black	NULL
bar	NULL
)	NULL
,	NULL
-750/CAT/HS-40	NULL
(	NULL
white	NULL
bar	NULL
)	NULL
,	NULL
or	NULL
-85/CAT/HS-40	NULL
(	NULL
stippled	NULL
bar	NULL
)	NULL
constructs	NULL
.	NULL

Data	NULL
represent	NULL
an	NULL
average	NULL
from	NULL
two	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
D	NULL
)	NULL
CAT	NULL
assays	NULL
from	NULL
K562	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
pSVOCAT	NULL
(	NULL
Control	NULL
)	NULL
,	NULL
-750/CAT/	NULL
Neo	NULL
,	NULL
-85/CAT/Neo	NULL
,	NULL
or	NULL
-55/CAT/Neo	NULL
with	NULL
HS-40	NULL
(	NULL
black	NULL
bar	NULL
)	NULL
or	NULL
without	NULL
HS-40	NULL
(	NULL
white	NULL
bar	NULL
)	NULL
.	NULL

Data	NULL
represent	NULL
an	NULL
average	NULL
from	NULL
four	NULL
independent	NULL
pools	NULL
of	NULL
stable	NULL
clones	NULL
(	NULL
>	NULL
100	NULL
clones	NULL
per	NULL
pool	NULL
)	NULL
per	NULL
construct	NULL
.	NULL

-750/CAT/HS-40/Neo	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

This	NULL
construct	NULL
is	NULL
identical	NULL
to	NULL
-85/CAT/HS-40/Neo	NULL
but	NULL
retains	NULL
a	NULL
190-bp	NULL
G+C-rich	NULL
region	NULL
containing	NULL
multiple	NULL
Spl-binding	NULL
sites	NULL
.	NULL

When	NULL
the	NULL
CCAAT	NULL
box	NULL
in	NULL
-750/CAT/HS-40/Neo	NULL
was	NULL
mutated	NULL
,	NULL
CAT	NULL
expression	NULL
from	NULL
pools	NULL
of	NULL
stable	NULL
MEL	NULL
cell	NULL
integrants	NULL
increased	NULL
4-fold	NULL
following	NULL
induction	NULL
with	NULL
HMBA	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

It	NULL
was	NULL
possible	NULL
that	NULL
the	NULL
similar	NULL
levels	NULL
of	NULL
expression	NULL
from	NULL
-750/CAT/HS-40	NULL
and	NULL
-85/CAT/HS-40	NULL
in	NULL
transiently	NULL
but	NULL
not	NULL
stably	NULL
transfected	NULL
cells	NULL
were	NULL
an	NULL
artifact	NULL
due	NULL
to	NULL
the	NULL
large	NULL
amount	NULL
of	NULL
DNA	NULL
employed	NULL
in	NULL
the	NULL
transient	NULL
transfections	NULL
(	NULL
50	NULL
ug	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
transfected	NULL
significantly	NULL
lower	NULL
concentrations	NULL
of	NULL
these	NULL
constructs	NULL
(	NULL
0.75	NULL
,	NULL
1.5	NULL
,	NULL
or	NULL
3.75	NULL
ug	NULL
)	NULL
into	NULL
Putko	NULL
cells	NULL
and	NULL
performed	NULL
CAT	NULL
assays	NULL
48	NULL
h	NULL
after	NULL
transfection	NULL
.	NULL

Putko	NULL
cells	NULL
were	NULL
chosen	NULL
for	NULL
this	NULL
experiment	NULL
since	NULL
we	NULL
have	NULL
found	NULL
that	NULL
they	NULL
transfect	NULL
with	NULL
higher	NULL
efficiency	NULL
than	NULL
MEL	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
showed	NULL
that	NULL
when	NULL
as	NULL
little	NULL
as	NULL
0.75	NULL
ug	NULL
of	NULL
construct	NULL
DNA	NULL
was	NULL
transiently	NULL
transfected	NULL
,	NULL
CAT	NULL
expression	NULL
levels	NULL
from	NULL
both	NULL
-85/	NULL
CAT/HS-40	NULL
and	NULL
-750/CAT/HS-40	NULL
were	NULL
similar	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

The	NULL
above	NULL
results	NULL
suggest	NULL
that	NULL
upon	NULL
stable	NULL
integration	NULL
into	NULL
chromatin	NULL
,	NULL
the	NULL
«	NULL
-globin	NULL
CCAAT	NULL
and	NULL
TATA	NULL
boxes	NULL
are	NULL
necessary	NULL
but	NULL
not	NULL
sufficient	NULL
for	NULL
optimal	NULL
levels	NULL
of	NULL
inducible	NULL
«	NULL
-globin	NULL
promoter	NULL
activity	NULL
.	NULL

A	NULL
combination	NULL
of	NULL
the	NULL
CCAAT	NULL
and	NULL
TATA	NULL
boxes	NULL
,	NULL
together	NULL
with	NULL
a	NULL
190-bp	NULL
G+C-rich	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
7239	NULL
containing	NULL
multiple	NULL
Spl-binding	NULL
sites	NULL
,	NULL
is	NULL
sufficient	NULL
for	NULL
full	NULL
-globin	NULL
promoter	NULL
activity	NULL
.	NULL

The	NULL
above	NULL
results	NULL
also	NULL
suggest	NULL
that	NULL
episomal	NULL
expression	NULL
of	NULL
-globin	NULL
CAT	NULL
constructs	NULL
somehow	NULL
bypasses	NULL
the	NULL
requirement	NULL
of	NULL
the	NULL
G+C-rich	NULL
region	NULL
for	NULL
full	NULL
-globin	NULL
promoter	NULL
activity	NULL
.	NULL

Clonal	NULL
Analysis	NULL
of	NULL
«	NULL
-Globin	NULL
Promoter	NULL
Activity	NULL
.	NULL

In	NULL
all	NULL
the	NULL
above	NULL
analyses	NULL
of	NULL
stably	NULL
transfected	NULL
a-globin	NULL
promoter/CAT/	NULL
HS-40/Neo	NULL
constructs	NULL
,	NULL
we	NULL
have	NULL
assumed	NULL
that	NULL
analyzing	NULL
complex	NULL
pools	NULL
of	NULL
K562	NULL
or	NULL
MEL	NULL
cell	NULL
clones	NULL
truly	NULL
reflects	NULL
the	NULL
mean	NULL
activity	NULL
of	NULL
individual	NULL
clones	NULL
.	NULL

To	NULL
test	NULL
this	NULL
assumption	NULL
we	NULL
analyzed	NULL
CAT	NULL
expression	NULL
from	NULL
10	NULL
individual	NULL
clones	NULL
of	NULL
MEL	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
either	NULL
a	NULL
-750/CAT/HS-40	NULL
or	NULL
a	NULL
-85/CAT/HS-40/	NULL
Neo	NULL
construct	NULL
.	NULL

Following	NULL
exposure	NULL
to	NULL
HMBA	NULL
,	NULL
CAT	NULL
activity	NULL
from	NULL
clones	NULL
containing	NULL
the	NULL
-750/CAT/HS-40/Neo	NULL
construct	NULL
increased	NULL
11-	NULL
to	NULL
22-fold	NULL
(	NULL
average	NULL
of	NULL
16-fold	NULL
)	NULL
compared	NULL
to	NULL
a	NULL
0-	NULL
to	NULL
8-fold	NULL
(	NULL
average	NULL
of	NULL
3-fold	NULL
)	NULL
induction	NULL
from	NULL
clones	NULL
containing	NULL
the	NULL
-85/CAT/HS-40/Neo	NULL
construct	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Overall	NULL
expression	NULL
levels	NULL
were	NULL
on	NULL
average	NULL
10-fold	NULL
higher	NULL
from	NULL
clones	NULL
containing	NULL
the	NULL
-750/CAT/HS-40/Neo	NULL
construct	NULL
compared	NULL
with	NULL
those	NULL
containing	NULL
the	NULL
-85/CAT/HS-40/Neo	NULL
construct	NULL
.	NULL

These	NULL
results	NULL
are	NULL
similar	NULL
to	NULL
what	NULL
we	NULL
observed	NULL
in	NULL
complex	NULL
pools	NULL
of	NULL
clones	NULL
containing	NULL
these	NULL
constructs	NULL
.	NULL

However	NULL
,	NULL
greater	NULL
variability	NULL
in	NULL
induction	NULL
levels	NULL
of	NULL
CAT	NULL
activity	NULL
was	NULL
observed	NULL
from	NULL
clones	NULL
containing	NULL
the	NULL
-85/	NULL
CAT	NULL
construct	NULL
(	NULL
0-	NULL
to	NULL
8-fold	NULL
)	NULL
compared	NULL
with	NULL
that	NULL
seen	NULL
from	NULL
clones	NULL
containing	NULL
the	NULL
-750/CAT/HS-40	NULL
construct	NULL
(	NULL
11-	NULL
to	NULL
20-fold	NULL
)	NULL
.	NULL

Overall	NULL
CAT	NULL
expression	NULL
levels	NULL
also	NULL
appeared	NULL
to	NULL
be	NULL
more	NULL
variable	NULL
from	NULL
clones	NULL
transfected	NULL
with	NULL
the	NULL
-85/CAT/HS-40/Neo	NULL
construct	NULL
compared	NULL
with	NULL
those	NULL
transfected	NULL
with	NULL
the	NULL
-750/CAT/	NULL
HS-40/Neo	NULL
construct	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
deletion	NULL
of	NULL
the	NULL
G+C-rich	NULL
region	NULL
5	NULL
'	NULL
of	NULL
the	NULL
-globin	NULL
CCAAT	NULL
box	NULL
not	NULL
only	NULL
reduces	NULL
-globin	NULL
promoter	NULL
activity	NULL
but	NULL
may	NULL
also	NULL
increase	NULL
variability	NULL
of	NULL
induction	NULL
and	NULL
expression	NULL
between	NULL
clones	NULL
,	NULL
possibly	NULL
due	NULL
to	NULL
the	NULL
effect	NULL
position	NULL
of	NULL
integration	NULL
has	NULL
on	NULL
expression	NULL
from	NULL
the	NULL
-85/	NULL
CAT	NULL
/HS-40/Neo	NULL
construct	NULL
.	NULL

Characterization	NULL
of	NULL
Transcription	NULL
Factors	NULL
Interacting	NULL
with	NULL
the	NULL
190-bp	NULL
G+C-Rich	NULL
a-Globin	NULL
5°	NULL
Flanking	NULL
Region	NULL
.	NULL

The	NULL
results	NULL
above	NULL
suggested	NULL
that	NULL
a	NULL
190-bp	NULL
G+C-rich	NULL
region	NULL
5	NULL
'	NULL
to	NULL
a-globin	NULL
's	NULL
CCAAT	NULL
box	NULL
may	NULL
be	NULL
an	NULL
important	NULL
regulator	NULL
of	NULL
a-globin	NULL
expression	NULL
in	NULL
stably	NULL
integrated	NULL
chromatin	NULL
.	NULL

To	NULL
study	NULL
the	NULL
interaction	NULL
of	NULL
this	NULL
region	NULL
with	NULL
nuclear	NULL
regulatory	NULL
factors	NULL
,	NULL
in	NULL
vitro	NULL
footprint	NULL
analysis	NULL
was	NULL
carried	NULL
out	NULL
on	NULL
a	NULL
210-bp	NULL
Nae	NULL
I-Eag	NULL
|	NULL
a-globin	NULL
promoter	NULL
fragment	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Whitelaw	NULL
et	NULL
al	NULL
.	NULL

(	NULL
17	NULL
)	NULL
showed	NULL
that	NULL
this	NULL
region	NULL
binds	NULL
Sp1	NULL
in	NULL
gel-shift	NULL
assays	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
specific	NULL
regions	NULL
of	NULL
this	NULL
flanking	NULL
region	NULL
capable	NULL
of	NULL
binding	NULL
Sp1	NULL
,	NULL
we	NULL
first	NULL
footprinted	NULL
the	NULL
region	NULL
by	NULL
using	NULL
recombinant	NULL
Sp1	NULL
.	NULL

Analysis	NULL
on	NULL
both	NULL
coding	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
and	NULL
noncoding	NULL
strands	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
indicated	NULL
four	NULL
clearly	NULL
protected	NULL
regions	NULL
.	NULL

Three	NULL
of	NULL
these	NULL
regions	NULL
correspond	NULL
to	NULL
consensus	NULL
Sp1-binding	NULL
MEL	NULL
cell	NULL
clones	NULL
U	NULL
udododododo	NULL
OWE	NULL
OOOOOG	NULL
-	NULL
NLG	NULL
-a	NULL
O	NULL
I	NULL
0	NULL
10	NULL
20	NULL
30	NULL
%	NULL
CAT	NULL
conversion	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

CAT	NULL
assays	NULL
from	NULL
pre-	NULL
(	NULL
white	NULL
bar	NULL
)	NULL
and	NULL
post-	NULL
(	NULL
black	NULL
bar	NULL
)	NULL
HMBA-induced	NULL
MEL	NULL
cell	NULL
clones	NULL
stably	NULL
transfected	NULL
with	NULL
-750/CAT/	NULL
HS-40/Neo	NULL
or	NULL
-85/CAT/HS-40/Neo	NULL
constructs	NULL
.	NULL

The	NULL
copy	NULL
number	NULL
of	NULL
the	NULL
construct	NULL
in	NULL
each	NULL
clone	NULL
is	NULL
indicated	NULL
.	NULL

7240	NULL
Genetics	NULL
:	NULL
Pondel	NULL
et	NULL
al	NULL
.	NULL

sites	NULL
,	NULL
and	NULL
the	NULL
other	NULL
region	NULL
contains	NULL
two	NULL
closely	NULL
spaced	NULL
CAC	NULL
boxes	NULL
.	NULL

One	NULL
additional	NULL
Sp1l-consensus	NULL
site	NULL
and	NULL
a	NULL
nonconsensus	NULL
site	NULL
also	NULL
bound	NULL
Sp1	NULL
but	NULL
not	NULL
as	NULL
strongly	NULL
as	NULL
the	NULL
other	NULL
sites	NULL
,	NULL
while	NULL
another	NULL
Sp1-consensus	NULL
site	NULL
showed	NULL
no	NULL
detectable	NULL
Sp1	NULL
binding	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
nonspecific	NULL
competitor	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
footprints	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

However	NULL
,	NULL
addition	NULL
of	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
an	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
consensus	NULL
Spl-binding	NULL
site	NULL
resulted	NULL
in	NULL
a	NULL
pattern	NULL
indistinguishable	NULL
from	NULL
that	NULL
observed	NULL
when	NULL
no	NULL
Sp1	NULL
was	NULL
added	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

When	NULL
the	NULL
210-bp	NULL
G+C-rich	NULL
region	NULL
was	NULL
footprinted	NULL
with	NULL
MEL	NULL
cell	NULL
nuclear	NULL
extracts	NULL
,	NULL
a	NULL
pattern	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
with	NULL
recombinant	NULL
Spl	NULL
was	NULL
obtained	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
consensus	NULL
and	NULL
nonconsensus	NULL
sites	NULL
that	NULL
weakly	NULL
bound	NULL
recombinant	NULL
Sp1	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
footprint	NULL
with	NULL
MEL	NULL
extracts	NULL
.	NULL

As	NULL
before	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
specific	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
but	NULL
not	NULL
nonspecific	NULL
competitor	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
resulted	NULL
in	NULL
a	NULL
pattern	NULL
indistinguishable	NULL
from	NULL
that	NULL
observed	NULL
when	NULL
no	NULL
extract	NULL
was	NULL
added	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
large	NULL
protected	NULL
region	NULL
from	NULL
-62	NULL
to	NULL
-90	NULL
corresponds	NULL
to	NULL
the	NULL
CCAAT	NULL
box	NULL
,	NULL
already	NULL
known	NULL
to	NULL
bind	NULL
Cpl	NULL
(	NULL
18	NULL
)	NULL
.	NULL

A	NULL
schematic	NULL
summary	NULL
of	NULL
these	NULL
data	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

~250	NULL
-	NULL
70	NULL
-	NULL
sith	NULL
bas	NULL
a	NULL
~260	NULL
-	NULL
a	NULL
1	NULL
2	NULL
3	NULL
4	NULL
3	NULL
4	NULL
°	NULL
5°	NULL
6	NULL
7	NULL
B	NULL
D	NULL
MEL	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
4D	NULL
.	NULL

Although	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
a	NULL
transcription	NULL
factor	NULL
other	NULL
than	NULL
Sp1	NULL
may	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
footprints	NULL
we	NULL
observe	NULL
with	NULL
MEL	NULL
cell	NULL
extract	NULL
,	NULL
preliminary	NULL
data	NULL
employing	NULL
anti-Spl	NULL
antibodies	NULL
suggest	NULL
this	NULL
is	NULL
not	NULL
the	NULL
case	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
results	NULL
of	NULL
our	NULL
footprint	NULL
analysis	NULL
,	NULL
therefore	NULL
,	NULL
suggest	NULL
that	NULL
the	NULL
only	NULL
detectable	NULL
nuclear	NULL
regulatory	NULL
factor	NULL
in	NULL
MEL	NULL
cells	NULL
binding	NULL
to	NULL
a-globin	NULL
's	NULL
190-bp	NULL
G+C-rich	NULL
region	NULL
is	NULL
Sp1	NULL
.	NULL

.	NULL

Addition	NULL
of	NULL
Spl	NULL
Binding	NULL
Sites	NULL
to	NULL
a	NULL
Minimal	NULL
«	NULL
-Globin	NULL
Promoter	NULL
Reconstitutes	NULL
High	NULL
Levels	NULL
of	NULL
Inducible	NULL
a-Globin	NULL
Promoter	NULL
Activity	NULL
.	NULL

To	NULL
provide	NULL
functional	NULL
evidence	NULL
for	NULL
the	NULL
role	NULL
of	NULL
Sp1	NULL
in	NULL
high	NULL
level	NULL
«	NULL
-globin	NULL
promoter	NULL
activity	NULL
,	NULL
we	NULL
constructed	NULL
a	NULL
modified	NULL
-85/CAT/HS-40/Neo	NULL
construct	NULL
in	NULL
which	NULL
six	NULL
synthetic	NULL
Sp1	NULL
or	NULL
mutant	NULL
Sp1	NULL
binding	NULL
sites	NULL
were	NULL
cloned	NULL
5	NULL
'	NULL
to	NULL
the	NULL
«	NULL
-globin	NULL
CCAAT	NULL
box	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

This	NULL
methodology	NULL
was	NULL
employed	NULL
rather	NULL
than	NULL
mutating	NULL
all	NULL
consensus	NULL
and	NULL
nonconsensus	NULL
Spi-binding	NULL
sites	NULL
in	NULL
the	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
since	NULL
this	NULL
would	NULL
require	NULL
extensive	NULL
mutagenesis	NULL
of	NULL
the	NULL
entire	NULL
region	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
due	NULL
to	NULL
the	NULL
G+C	NULL
richness	NULL
of	NULL
the	NULL
region	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
other	NULL
potential	NULL
Sp1-binding	NULL
sites	NULL
not	NULL
detected	NULL
in	NULL
our	NULL
footprint	NULL
analysis	NULL
are	NULL
present	NULL
.	NULL

The	NULL
above	NULL
constructs	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
-750/	NULL
C	NULL
MEL	NULL
extract	NULL
~240	NULL
~200	NULL
-180	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Footprint	NULL
analysis	NULL
of	NULL
the	NULL
a-globin	NULL
promoter	NULL
from	NULL
-60	NULL
to	NULL
-270	NULL
.	NULL

(	NULL
4	NULL
)	NULL
DNase	NULL
-160	NULL
protection	NULL
of	NULL
the	NULL
noncoding	NULL
strand	NULL
of	NULL
the	NULL
«	NULL
-globin	NULL
promoter	NULL
by	NULL
recombinant	NULL
human	NULL
Sp1	NULL
(	NULL
rSp1	NULL
)	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
G	NULL
+	NULL
A	NULL
sequence	NULL
of	NULL
the	NULL
-140	NULL
probe	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
,	NULL
DNase	NULL
digestion	NULL
of	NULL
the	NULL
-130	NULL
probe	NULL
with	NULL
increasing	NULL
DNase	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
DNase	NULL
digestion	NULL
after	NULL
incubation	NULL
of	NULL
the	NULL
probe	NULL
with	NULL
2	NULL
-120	NULL
ul	NULL
of	NULL
rSpl	NULL
.	NULL

(	NULL
B	NULL
)	NULL
DNase	NULL
protection	NULL
of	NULL
the	NULL
coding	NULL
strand	NULL
of	NULL
the	NULL
a-globin	NULL
promoter	NULL
by	NULL
-110	NULL
Spl	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
G	NULL
+	NULL
A	NULL
sequence	NULL
of	NULL
the	NULL
probe	NULL
;	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
,	NULL
DNase	NULL
digestion	NULL
of	NULL
the	NULL
probe	NULL
.-100	NULL
with	NULL
increasing	NULL
DNase	NULL
.	NULL

In	NULL
lanes	NULL
4	NULL
to	NULL
8	NULL
,	NULL
various	NULL
amounts	NULL
of	NULL
rSpl	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
probe	NULL
before	NULL
digestion	NULL
with	NULL
DNase	NULL
.	NULL

Lane	NULL
4	NULL
,	NULL
-930	NULL
0.5	NULL
ul	NULL
of	NULL
rSp1	NULL
;	NULL
lane	NULL
5	NULL
,	NULL
1	NULL
ul	NULL
of	NULL
rSp1	NULL
;	NULL
lanes	NULL
6-8	NULL
,	NULL
2	NULL
ul	NULL
of	NULL
rSpl	NULL
;	NULL
lane	NULL
7	NULL
,	NULL
the	NULL
reaction	NULL
mixture	NULL
s	NULL
contained	NULL
a	NULL
100	NULL
%	NULL
molar	NULL
excess	NULL
of	NULL
a	NULL
double-l	NULL
stranded	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mu-	NULL
,	NULL
tated	NULL
Sp1-binding	NULL
site	NULL
;	NULL
and	NULL
lane	NULL
8	NULL
,	NULL
the	NULL
reac	NULL
--	NULL
so	NULL
-|	NULL
&	NULL
m	NULL
tion	NULL
mixture	NULL
contained	NULL
a	NULL
100	NULL
%	NULL
molar	NULL
excess	NULL
of	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
consensus	NULL
Spi-binding	NULL
site	NULL
.	NULL

(	NULL
C	NULL
)	NULL
DNase	NULL
protection	NULL
of	NULL
the	NULL
coding	NULL
strand	NULL
of	NULL
the	NULL
a-globin	NULL
promoter	NULL
by	NULL
nuclear	NULL
extract	NULL
from	NULL
MEL	NULL
-70	NULL
-	NULL
tissue	NULL
culture	NULL
cells	NULL
.	NULL

Lane	NULL
1	NULL
,	NULL
G	NULL
+	NULL
A	NULL
sequence	NULL
of	NULL
the	NULL
probe	NULL
;	NULL
lane	NULL
2	NULL
,	NULL
DNase	NULL
digestion	NULL
of	NULL
the	NULL
probe	NULL
;	NULL
lanes	NULL
3-5	NULL
,	NULL
DNase	NULL
digestion	NULL
of	NULL
the	NULL
wma	NULL
_	NULL
probe	NULL
after	NULL
incubation	NULL
with	NULL
10	NULL
pg	NULL
of	NULL
nuclear	NULL
extract	NULL
from	NULL
MEL	NULL
cells	NULL
;	NULL
lane	NULL
4	NULL
,	NULL
the	NULL
reaction	NULL
mixture	NULL
contained	NULL
a	NULL
100	NULL
%	NULL
molar	NULL
excess	NULL
of	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
mutated	NULL
Spl-binding	NULL
site	NULL
;	NULL
and	NULL
lane	NULL
5	NULL
,	NULL
the	NULL
*	NULL
reaction	NULL
mixture	NULL
contained	NULL
a	NULL
100	NULL
%	NULL
molar	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
_	NULL
excess	NULL
of	NULL
a	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
a	NULL
consensus	NULL
Sp1-binding	NULL
site	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Schematic	NULL
representation	NULL
of	NULL
the	NULL
results	NULL
from	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C.	NULL
Consensus	NULL
Sp1-binding	NULL
sites	NULL
are	NULL
indicated	NULL
as	NULL
black	NULL
boxes	NULL
and	NULL
the	NULL
CCAAT	NULL
box	NULL
a	NULL
extract	NULL
a	NULL
?	NULL

v	NULL
T	NULL
?	NULL

v	NULL
'	NULL
£	NULL
'	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
open	NULL
box	NULL
.	NULL

Protection	NULL
from	NULL
rSp1	NULL
-280	NULL
-260	NULL
-240	NULL
-220	NULL
-200	NULL
-180	NULL
-~160	NULL
-140	NULL
DNase	NULL
digestion	NULL
is	NULL
indicated	NULL
by	NULL
brackets	NULL
ei-	NULL
I	NULL
'	NULL
Y	NULL
~I	NULL
'	NULL
'~	NULL
``	NULL
f	NULL
°	NULL
_n	NULL
ther	NULL
above	NULL
the	NULL
line	NULL
(	NULL
coding	NULL
strand	NULL
)	NULL
or	NULL
below	NULL
--	NULL
it	NULL
;	NULL
i-	NULL
the	NULL
tine	NULL
{	NULL
noncoding	NULL
strand	NULL
)	NULL
.	NULL

Hypersensitive	NULL
-120	NULL
-100	NULL
_	NULL
-80	NULL
-60	NULL
sites	NULL
are	NULL
indicated	NULL
by	NULL
arrows	NULL
.	NULL

Relatively	NULL
weak	NULL
rSp1	NULL
f	NULL
15m	NULL
sol	NULL
)	NULL
|	NULL
``	NULL
J	NULL
hae	NULL
Line	NULL
of	NULL
protection	NULL
is	NULL
indicated	NULL
by	NULL
broken	NULL
lines	NULL
.	NULL

Genetics	NULL
:	NULL
Pondel	NULL
et	NULL
al	NULL
.	NULL

40	NULL
%	NULL
CAT	NULL
conversion	NULL
uo	NULL
7	NULL
$	NULL
bus	NULL
&	NULL
|	NULL
o	NULL
-k	NULL
-I	NULL
uh	NULL
Q	NULL
-750	NULL
Sp1/-85	NULL
Sp1*/-85	NULL
«	NULL
-Globin	NULL
construct	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

CAT	NULL
assay	NULL
from	NULL
pre-	NULL
(	NULL
white	NULL
bar	NULL
)	NULL
or	NULL
post-	NULL
(	NULL
black	NULL
bar	NULL
)	NULL
HMBA-treated	NULL
MEL	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
-750/CAT/HS-40/Neo	NULL
,	NULL
-85/CAT/HS-40/Neo	NULL
,	NULL
Sp1/-85/CAT/HS-40/Neo	NULL
,	NULL
or	NULL
Sp1*/-85/CAT/HS-40/Neo	NULL
constructs	NULL
.	NULL

Data	NULL
represent	NULL
an	NULL
average	NULL
from	NULL
four	NULL
independent	NULL
pools	NULL
of	NULL
stable	NULL
clones	NULL
(	NULL
>	NULL
100	NULL
clones	NULL
per	NULL
pool	NULL
)	NULL
per	NULL
construct	NULL
.	NULL

CAT/HS-40	NULL
and	NULL
-85/CAT/HS-40/Neo	NULL
constructs	NULL
,	NULL
were	NULL
stably	NULL
transfected	NULL
into	NULL
MEL	NULL
cells	NULL
,	NULL
and	NULL
expression	NULL
levels	NULL
were	NULL
analyzed	NULL
from	NULL
complex	NULL
pools	NULL
of	NULL
G418-resistant	NULL
cell	NULL
clones	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
shows	NULL
that	NULL
CAT	NULL
expression	NULL
data	NULL
from	NULL
pools	NULL
of	NULL
clones	NULL
containing	NULL
the	NULL
Sp1/-85/CAT/HS-40/Neo	NULL
construct	NULL
gave	NULL
as	NULL
high	NULL
a	NULL
level	NULL
of	NULL
inducible	NULL
«	NULL
-globin	NULL
promoter	NULL
activity	NULL
as	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
-750/CAT/HS-40/Neo	NULL
construct	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
mutant	NULL
Sp1*/-85/CAT/HS-40/Neo	NULL
construct	NULL
gave	NULL
83-86	NULL
%	NULL
lower	NULL
levels	NULL
of	NULL
expression	NULL
,	NULL
similar	NULL
to	NULL
that	NULL
seen	NULL
from	NULL
the	NULL
-85/CAT/HS-40/Neo	NULL
construct	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
the	NULL
multiple	NULL
Sp1-binding	NULL
sites	NULL
in	NULL
the	NULL
190-bp	NULL
G+C-rich	NULL
region	NULL
of	NULL
the	NULL
-globin	NULL
promoter	NULL
are	NULL
crucial	NULL
for	NULL
high-level	NULL
-globin	NULL
promoter	NULL
activity	NULL
from	NULL
a	NULL
stably	NULL
integrated	NULL
a-globin	NULL
construct	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
maximum	NULL
a-globin	NULL
promoter	NULL
activity	NULL
from	NULL
a	NULL
stably	NULL
integrated	NULL
a-globin	NULL
construct	NULL
linked	NULL
to	NULL
HS-40	NULL
requires	NULL
a	NULL
190-bp	NULL
G+C-rich	NULL
region	NULL
located	NULL
immediately	NULL
5	NULL
'	NULL
to	NULL
the	NULL
«	NULL
-globin	NULL
CCAAT	NULL
box	NULL
.	NULL

Promoter	NULL
activity	NULL
from	NULL
a	NULL
stably	NULL
integrated	NULL
construct	NULL
that	NULL
lacks	NULL
this	NULL
region	NULL
increased	NULL
less	NULL
than	NULL
2-fold	NULL
following	NULL
HMBA-induced	NULL
MEL	NULL
cell	NULL
differentiation	NULL
.	NULL

By	NULL
comparison	NULL
,	NULL
a-globin	NULL
promoter	NULL
activity	NULL
from	NULL
a	NULL
stably	NULL
integrated	NULL
construct	NULL
that	NULL
retained	NULL
this	NULL
region	NULL
increased	NULL
10-	NULL
to	NULL
20-fold	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
the	NULL
G+C-rich	NULL
region	NULL
to	NULL
increase	NULL
a-globin	NULL
expression	NULL
in	NULL
stably	NULL
integrated	NULL
but	NULL
not	NULL
in	NULL
episomal	NULL
DNA	NULL
is	NULL
similar	NULL
to	NULL
findings	NULL
showing	NULL
hypersensitive	NULL
sites	NULL
1	NULL
,	NULL
3	NULL
,	NULL
and	NULL
4	NULL
of	NULL
the	NULL
B	NULL
locus	NULL
control	NULL
region	NULL
can	NULL
increase	NULL
promoter	NULL
activity	NULL
of	NULL
a	NULL
linked	NULL
gene	NULL
only	NULL
when	NULL
integrated	NULL
into	NULL
chromatin	NULL
(	NULL
19-23	NULL
)	NULL
.	NULL

Recently	NULL
,	NULL
an	NULL
element	NULL
within	NULL
stem-cell	NULL
antigen	NULL
CD34	NULL
chromatin	NULL
has	NULL
also	NULL
been	NULL
found	NULL
to	NULL
act	NULL
as	NULL
an	NULL
enhancer	NULL
only	NULL
in	NULL
stably	NULL
integrated	NULL
DNA	NULL
(	NULL
24	NULL
)	NULL
.	NULL

It	NULL
is	NULL
tempting	NULL
to	NULL
suggest	NULL
that	NULL
these	NULL
elements	NULL
may	NULL
employ	NULL
a	NULL
common	NULL
mechanism	NULL
to	NULL
increase	NULL
expression	NULL
from	NULL
a	NULL
linked	NULL
gene	NULL
.	NULL

The	NULL
results	NULL
of	NULL
our	NULL
in	NULL
vitro	NULL
footprint	NULL
analysis	NULL
show	NULL
that	NULL
multiple	NULL
consensus	NULL
and	NULL
nonconsensus	NULL
Spl-binding	NULL
sites	NULL
present	NULL
in	NULL
the	NULL
-globin	NULL
G+C-rich	NULL
flanking	NULL
region	NULL
are	NULL
capable	NULL
of	NULL
binding	NULL
both	NULL
recombinant	NULL
Sp1	NULL
and	NULL
Sp1	NULL
present	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
MEL	NULL
cells	NULL
.	NULL

No	NULL
other	NULL
transcription	NULL
factors	NULL
interacting	NULL
with	NULL
this	NULL
region	NULL
were	NULL
detected	NULL
.	NULL

When	NULL
synthetic	NULL
Sp1-binding	NULL
sites	NULL
were	NULL
added	NULL
5°	NULL
of	NULL
the	NULL
CCAAT	NULL
box	NULL
in	NULL
a	NULL
minimal	NULL
-globin	NULL
promoter	NULL
construct	NULL
,	NULL
expression	NULL
from	NULL
the	NULL
stably	NULL
integrated	NULL
construct	NULL
was	NULL
identical	NULL
to	NULL
that	NULL
from	NULL
a	NULL
construct	NULL
con	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92	NULL
(	NULL
1995	NULL
)	NULL
7241	NULL
taining	NULL
the	NULL
entire	NULL
190-bp	NULL
G+C-rich	NULL
region	NULL
.	NULL

These	NULL
results	NULL
,	NULL
along	NULL
with	NULL
the	NULL
data	NULL
showing	NULL
that	NULL
mutated	NULL
Sp1	NULL
sites	NULL
no	NULL
longer	NULL
increase	NULL
promoter	NULL
activity	NULL
,	NULL
strongly	NULL
suggest	NULL
that	NULL
multiple	NULL
Spi-binding	NULL
sites	NULL
,	NULL
rather	NULL
than	NULL
the	NULL
G+C	NULL
richness	NULL
of	NULL
this	NULL
region	NULL
,	NULL
are	NULL
responsible	NULL
for	NULL
the	NULL
ability	NULL
of	NULL
this	NULL
region	NULL
to	NULL
increase	NULL
expression	NULL
from	NULL
a	NULL
stably	NULL
integrated	NULL
«	NULL
-globin	NULL
gene	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
expression	NULL
from	NULL
a	NULL
stably	NULL
integrated	NULL
minimal	NULL
«	NULL
-globin	NULL
promoter	NULL
(	NULL
CCAAT	NULL
and	NULL
TATA	NULL
sequences	NULL
only	NULL
)	NULL
construct	NULL
in	NULL
individual	NULL
clones	NULL
is	NULL
low	NULL
and	NULL
variable	NULL
suggests	NULL
that	NULL
deletion	NULL
of	NULL
the	NULL
G+C-rich	NULL
region	NULL
increases	NULL
the	NULL
effect	NULL
position	NULL
of	NULL
integration	NULL
has	NULL
on	NULL
a-globin	NULL
promoter	NULL
activity	NULL
.	NULL

A	NULL
plausible	NULL
hypothesis	NULL
is	NULL
that	NULL
the	NULL
«	NULL
-globin	NULL
G+C-rich	NULL
region	NULL
may	NULL
act	NULL
by	NULL
altering	NULL
chromatin	NULL
structure	NULL
around	NULL
the	NULL
a-globin	NULL
pro-moter	NULL
,	NULL
allowing	NULL
it	NULL
greater	NULL
access	NULL
to	NULL
transcription	NULL
factors	NULL
that	NULL
are	NULL
differentially	NULL
expressed	NULL
during	NULL
erythroid	NULL
development	NULL
.	NULL

Since	NULL
Sp1	NULL
is	NULL
clearly	NULL
present	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
uninduced	NULL
MEL	NULL
cells	NULL
,	NULL
it	NULL
would	NULL
follow	NULL
that	NULL
such	NULL
an	NULL
``	NULL
open	NULL
``	NULL
chromatin	NULL
conformation	NULL
is	NULL
set	NULL
up	NULL
prior	NULL
to	NULL
terminal	NULL
erythroid	NULL
differentiation	NULL
.	NULL

This	NULL
hypothesis	NULL
is	NULL
supported	NULL
by	NULL
Vyas	NULL
et	NULL
al	NULL
.	NULL

(	NULL
6	NULL
)	NULL
,	NULL
who	NULL
showed	NULL
that	NULL
the	NULL
a-globin	NULL
gene	NULL
cluster	NULL
,	NULL
as	NULL
a	NULL
whole	NULL
,	NULL
is	NULL
in	NULL
a	NULL
constitutively	NULL
open	NULL
chromatin	NULL
conformation	NULL
.	NULL

Many	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
Sp1	NULL
can	NULL
activate	NULL
transcription	NULL
from	NULL
various	NULL
promoters	NULL
(	NULL
25-29	NULL
)	NULL
.	NULL

However	NULL
,	NULL
so	NULL
far	NULL
as	NULL
we	NULL
know	NULL
,	NULL
a	NULL
chromatin-dependent	NULL
effect	NULL
of	NULL
Spl	NULL
has	NULL
not	NULL
been	NULL
reported	NULL
previously	NULL
.	NULL

We	NULL
thank	NULL
Drs	NULL
.	NULL

D.	NULL
Higgs	NULL
and	NULL
W.	NULL
Wood	NULL
for	NULL
useful	NULL
discussions	NULL
and	NULL
encouragement	NULL
throughout	NULL
these	NULL
studies	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
a	NULL
Wellcome	NULL
project	NULL
grant	NULL
(	NULL
034217	NULL
)	NULL
to	NULL
N.J.P	NULL
.	NULL

and	NULL
M.D.P	NULL
.	NULL

1	NULL
.	NULL

Higgs	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Vickers	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Wilkie	NULL
,	NULL
A.	NULL
O.	NULL
M.	NULL
,	NULL
Pretorius	NULL
,	NULL
L-M.	NULL
,	NULL
Jarman	NULL
,	NULL
A.	NULL
P.	NULL
&	NULL
Weatherall	NULL
,	NULL
D.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Blood	NULL
73	NULL
,	NULL
1081-1104	NULL
.	NULL

2	NULL
.	NULL

Higgs	NULL
,	NULL
D.	NULL
R.	NULL
,	NULL
Wood	NULL
,	NULL
W.	NULL
G.	NULL
,	NULL
Jarman	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
Sharpe	NULL
,	NULL
J.	NULL
,	NULL
Lida	NULL
,	NULL
J.	NULL
,	NULL
Pretorius	NULL
,	NULL
I.	NULL
M.	NULL
&	NULL
Ayyub	NULL
,	NULL
H.	NULL
(	NULL
1990	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

4	NULL
,	NULL
1588-1601	NULL
.	NULL

3	NULL
.	NULL

Jarman	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
Wood	NULL
,	NULL
W.	NULL
G.	NULL
,	NULL
Sharpe	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Gourdon	NULL
,	NULL
G.	NULL
,	NULL
Ayyub	NULL
,	NULL
H.	NULL
&	NULL
Higgs	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
4679-4689	NULL
.	NULL

4	NULL
.	NULL

-	NULL
Pondel	NULL
,	NULL
M.	NULL
,	NULL
Proudfoot	NULL
,	NULL
N.	NULL
J.	NULL
,	NULL
Whitelaw	NULL
,	NULL
C.	NULL
&	NULL
Whitelaw	NULL
,	NULL
E.	NULL
(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
5655-5660	NULL
.	NULL

5	NULL
.	NULL

Sharpe	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Wells	NULL
,	NULL
J.	NULL
,	NULL
Whitelaw	NULL
,	NULL
E.	NULL
,	NULL
Vyas	NULL
,	NULL
P.	NULL
,	NULL
Higgs	NULL
,	NULL
D.	NULL
R.	NULL
&	NULL
Wood	NULL
,	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90	NULL
,	NULL
11262-11266	NULL
.	NULL

6	NULL
.	NULL

Vyas	NULL
,	NULL
P.	NULL
,	NULL
Vickers	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Simmons	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Ayyub	NULL
,	NULL
H.	NULL
,	NULL
Craddock	NULL
,	NULL
C.	NULL
F.	NULL
&	NULL
Higgs	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
69	NULL
,	NULL
781-793	NULL
.	NULL

7	NULL
.	NULL

Bird	NULL
,	NULL
A.	NULL
P.	NULL
,	NULL
Taggart	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Nicholls	NULL
,	NULL
R.	NULL
D.	NULL
&	NULL
Higgs	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1987	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

6	NULL
,	NULL
999-1004	NULL
.	NULL

Tazi	NULL
,	NULL
J	NULL
.	NULL

&	NULL
Bird	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Cell	NULL
60	NULL
,	NULL
909-920	NULL
.	NULL

Gorman	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
Moffat	NULL
,	NULL
L.	NULL
&	NULL
Howard	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

2	NULL
,	NULL
1044-1051	NULL
.	NULL

10	NULL
.	NULL

-	NULL
Pondel	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
George	NULL
,	NULL
M.	NULL
&	NULL
Proudfoot	NULL
,	NULL
N.	NULL
J	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20	NULL
,	NULL
237-243	NULL
.	NULL

11	NULL
.	NULL

-	NULL
Maniatis	NULL
,	NULL
T.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
&	NULL
Sambrook	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1982	NULL
)	NULL
Molecular	NULL
Cloning	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
(	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Lab	NULL
.	NULL

Press	NULL
,	NULL
Plainview	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

12	NULL
.	NULL

Murphy	NULL
,	NULL
S.	NULL
,	NULL
Yoon	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Gerster	NULL
,	NULL
T.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12	NULL
,	NULL
3247-3261	NULL
.	NULL

13	NULL
.	NULL

Dignam	NULL
,	NULL
J.	NULL
D.	NULL
,	NULL
Lebowitz	NULL
,	NULL
R.	NULL
M.	NULL
&	NULL
Roeder	NULL
,	NULL
R.	NULL
G.	NULL
(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

11	NULL
,	NULL
1475-1489	NULL
.	NULL

14	NULL
.	NULL

-	NULL
Marks	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

&	NULL
Rifkind	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1978	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

47	NULL
,	NULL
419-448	NULL
.	NULL

15	NULL
.	NULL

Marks	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Sheffery	NULL
,	NULL
M.	NULL
&	NULL
Rifkind	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Cancer	NULL
Res	NULL
,	NULL
47	NULL
,	NULL
659-666	NULL
.	NULL

16	NULL
.	NULL

Tsiftsoglou	NULL
,	NULL
A.	NULL
S.	NULL
&	NULL
Robinson	NULL
,	NULL
S.	NULL
H.	NULL
(	NULL
1985	NULL
)	NULL
Int	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Cloning	NULL
3	NULL
,	NULL
349-366	NULL
.	NULL

17	NULL
.	NULL

Whitelaw	NULL
,	NULL
E.	NULL
,	NULL
Hobgen	NULL
,	NULL
P.	NULL
,	NULL
Hanscombe	NULL
,	NULL
O	NULL
.	NULL

&	NULL
Proudfoot	NULL
,	NULL
N.	NULL
J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
,	NULL
241-251	NULL
.	NULL

18	NULL
.	NULL

-	NULL
Chodosh	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Baldwin	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
Carthew	NULL
,	NULL
R.	NULL
W.	NULL
&	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Cell	NULL
§3	NULL
,	NULL
11-24	NULL
.	NULL

19	NULL
.	NULL

-	NULL
Grosveld	NULL
,	NULL
F.	NULL
,	NULL
Blom	NULL
Van	NULL
Assendelft	NULL
,	NULL
G.	NULL
,	NULL
Greaves	NULL
,	NULL
D.	NULL
R.	NULL
&	NULL
Kollias	NULL
,	NULL
G.	NULL
(	NULL
1987	NULL
)	NULL
Cell	NULL
51	NULL
,	NULL
974-985	NULL
.	NULL

20	NULL
.	NULL

Talbot	NULL
,	NULL
D.	NULL
,	NULL
Collis	NULL
,	NULL
P.	NULL
,	NULL
Antoniou	NULL
,	NULL
M.	NULL
,	NULL
Vidal	NULL
,	NULL
M.	NULL
,	NULL
Grosveld	NULL
,	NULL
F.	NULL
&	NULL
Greaves	NULL
,	NULL
D.	NULL
R.	NULL
(	NULL
1989	NULL
)	NULL
Nature	NULL
(	NULL
London	NULL
)	NULL
338	NULL
,	NULL
352-355	NULL
.	NULL

21	NULL
.	NULL

-	NULL
Forrester	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Novak	NULL
,	NULL
U.	NULL
,	NULL
Gelinas	NULL
,	NULL
R.	NULL
&	NULL
Groudine	NULL
,	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
5439-5443	NULL
.	NULL

22	NULL
.	NULL

Tuan	NULL
,	NULL
D.	NULL
,	NULL
Solomon	NULL
,	NULL
W.	NULL
,	NULL
Quiliang	NULL
,	NULL
L.	NULL
$	NULL
.	NULL

&	NULL
Irving	NULL
,	NULL
M.	NULL
L.	NULL
(	NULL
1985	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82	NULL
,	NULL
6384-6388	NULL
.	NULL

23	NULL
.	NULL

-	NULL
Tuan	NULL
,	NULL
D.	NULL
,	NULL
Solomon	NULL
,	NULL
W.	NULL
,	NULL
London	NULL
,	NULL
I	NULL
.	NULL

&	NULL
Lee	NULL
,	NULL
D.	NULL
(	NULL
1989	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86	NULL
,	NULL
2554-2558	NULL
.	NULL

24	NULL
.	NULL

-	NULL
May	NULL
,	NULL
G.	NULL
&	NULL
Enver	NULL
,	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

14	NULL
,	NULL
564-574	NULL
.	NULL

25	NULL
.	NULL

Tasanen	NULL
,	NULL
K.	NULL
,	NULL
Oikarinen	NULL
,	NULL
J.	NULL
,	NULL
Kivirikko	NULL
,	NULL
K.	NULL
1	NULL
.	NULL

&	NULL
Pihlajaniemi	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
Biochem	NULL
.	NULL

J	NULL
.	NULL

292	NULL
,	NULL
41-45	NULL
.	NULL

26	NULL
.	NULL

Pogulis	NULL
,	NULL
R.	NULL
J	NULL
.	NULL

&	NULL
Freytag	NULL
,	NULL
S.	NULL
O	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Bio	NULL
!	NULL

.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
2493-2499	NULL
.	NULL

27	NULL
.	NULL

-	NULL
Gidoni	NULL
,	NULL
D.	NULL
,	NULL
Kadonaga	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
Barrera-Saldana	NULL
,	NULL
H.	NULL
,	NULL
Takahashi	NULL
,	NULL
K.	NULL
,	NULL
Chambon	NULL
,	NULL
P.	NULL
&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
230	NULL
,	NULL
511-517	NULL
.	NULL

28	NULL
.	NULL

Jones	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
Yamamoto	NULL
,	NULL
K.	NULL
R.	NULL
&	NULL
Tjian	NULL
,	NULL
R.	NULL
(	NULL
1985	NULL
)	NULL
Cell	NULL
42	NULL
,	NULL
559-572	NULL
.	NULL

10	NULL
go	NULL

